PASCA, SAMANTHA
 Distribuzione geografica
Continente #
NA - Nord America 4.055
EU - Europa 619
AS - Asia 589
AF - Africa 4
OC - Oceania 3
SA - Sud America 3
Totale 5.273
Nazione #
US - Stati Uniti d'America 4.044
SG - Singapore 294
CN - Cina 221
FR - Francia 153
IT - Italia 146
FI - Finlandia 116
GB - Regno Unito 67
VN - Vietnam 53
DE - Germania 42
SE - Svezia 35
UA - Ucraina 16
IE - Irlanda 14
CA - Canada 10
RU - Federazione Russa 9
HK - Hong Kong 5
IN - India 5
NL - Olanda 5
TR - Turchia 4
AT - Austria 3
BG - Bulgaria 3
CH - Svizzera 3
ES - Italia 3
TN - Tunisia 3
AU - Australia 2
GR - Grecia 2
JP - Giappone 2
KR - Corea 2
AM - Armenia 1
BR - Brasile 1
BY - Bielorussia 1
CL - Cile 1
MA - Marocco 1
MX - Messico 1
NZ - Nuova Zelanda 1
PE - Perù 1
PH - Filippine 1
PT - Portogallo 1
TH - Thailandia 1
Totale 5.273
Città #
Fairfield 808
Woodbridge 365
Houston 280
Ashburn 276
Seattle 263
Ann Arbor 261
Cambridge 233
Singapore 225
Wilmington 194
San Diego 179
Medford 166
Princeton 166
Roxbury 141
Chandler 121
Des Moines 120
Helsinki 91
Guangzhou 66
Dong Ket 53
Shanghai 46
Beijing 37
Santa Clara 37
Padova 23
Boardman 21
New York 18
London 17
Dublin 14
Nanjing 14
Kharkiv 13
Borås 11
Ogden 10
Brendola 9
Norwalk 9
Hounslow 7
Milan 7
Nanchang 7
Naples 7
Rome 7
Turin 7
Redmond 5
Southwark 5
Trieste 5
Venice 5
Amsterdam 4
Cagliari 4
Hong Kong 4
Kilburn 4
Rockville 4
Shenyang 4
Campobasso 3
Dallas 3
Fremont 3
Las Vegas 3
Sofia 3
Vienna 3
Ansbach 2
Bari 2
Castel Gabbiano 2
Catania 2
Catanzaro 2
Chiswick 2
Duino-Aurisina 2
Frankfurt am Main 2
Hebei 2
Izmir 2
Kansas City 2
Marseille 2
Messina 2
Mezzano 2
Mykolayiv 2
Newcastle upon Tyne 2
Palermo 2
Paris 2
Pescara 2
Pomezia 2
Prescot 2
Pune 2
Pátrai 2
Redwood City 2
Rovereto 2
San Giovanni Rotondo 2
Seoul 2
Stoke-on-Trent 2
Storo 2
Tianjin 2
Toronto 2
Trento 2
Villeurbanne 2
Washington 2
Alliston 1
Apex 1
Bangkok 1
Berlin 1
Boisar 1
Bologna 1
Bolzano 1
Bridgewater 1
Brighton 1
Brolo 1
Casavatore 1
Cassino 1
Totale 4.471
Nome #
Pulmonary embolism and 3-month outcomes in 4036 patients with venous thromboembolism and chronic obstructive pulmonary disease: data from the RIETE registry 101
Fondaparinux in the initial and long-term treatment of venous thromboembolism 100
Acute venous thromboembolism after non-major orthopaedic surgery or post-traumatic limb immobilisation 99
Thirty-day mortality rate in women with cancer and venous thromboembolism. Findings from the RIETE Registry 99
Silent pulmonary embolism in patients with proximal deep vein thrombosis in the lower limbs 98
Tailored prophylaxis with rFXIII (NovoThirteen ® ) in a young girl with severe FXIII deficiency and previous cephalohaematoma 96
Thrombolytic therapy and outcome of patients with an acute symptomatic pulmonary embolism 88
A clinical prognostic model for the identification of low-risk patients with acute symptomatic pulmonary embolism and active cancer. 87
Factors Associated with elevated Pulmonary Arterial Pressure Levels on the Echocardiographic Assessment in Patients with Prior Pulmonary Embolism 85
Long-term therapy with low-molecular-weight heparin in cancer patients with venous thromboembolism 84
Unsuspected pulmonary embolism in patients with cancer 84
Validation of a score for predicting fatal bleeding in patients receiving anticoagulation for venous thromboembolism 83
Clinical presentation and outcome of venous thromboembolism in COPD 81
Venous thromboembolism in immobilized patients with dementia. Findings from the RIETE registry. 77
D-dimer levels and 90-day outcome in patients with acute pulmonary embolism with or without cancer 74
Acquired haemophilia A, concomitant acute myocardial infarction and urgent major surgery: How to successfully treat a critical patient with rpFVIII (Obizur®) 72
La patologia cerebro e cardiovascolare nel paziente emofilico adulto dall’epidemiologia al trattamento. Registro multicentrico, retrospettivo-prospettico. 67
Consensus statements on vaccination in patients with haemophilia—Results from the Italian haemophilia and vaccinations (HEVA) project 66
null 64
Influence of recent immobilization and recent surgery on mortality in patients with pulmonary embolism 64
Clinical significance of a negative D-dimer level in patients with confirmed venous thromboembolism. Findings from the RIETE Registry 61
Platelet count and outcome in patients with acute venous thromboembolism 61
Activated prothrombin complex concentrate (FEIBA ® ) in acquired haemophilia A: a large multicentre Italian study – the FAIR Registry 61
ABO Blood Group and Inhibitor Risk in Severe Hemophilia A Patients: A Study from the Italian Association of Hemophilia Centers 60
Low-molecular-weight or Unfractionated Heparin in Venous Thromboembolism: The Influence of Renal Function 58
Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism 55
Usefulness of Thrombophilia Testing in Venous Thromboembolic Disease: Findings From the RIETE Registry 55
Effects of age on the risk of dying from pulmonary embolism or bleeding during treatment of deep vein thrombosis 54
Outcomes in Neurosurgical Patients Who Develop Venous Thromboembolism: A Review of the RIETE Registry 52
How haemophilia A impacts severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) treatment: a case report 52
Regenerative Surgery with Dental Implant Rehabilitation in a Haemophiliac Patient 51
A prognostic score to identify low-risk outpatients with acute deep vein thrombosis in the upper extremity 51
Immunosuppression for acquired hemophilia A: Results from the European Acquired Haemophilia Registry (EACH2) 50
PK-driven prophylaxis versus standard prophylaxis: When a tailored treatment may be a real and achievable cost-saving approach in children with severe hemophilia A 47
Cerebrovascular diseases in hemophiliacs: A real, but underestimated risk 47
The management of acute venous thromboembolism in clinical practice - study rationale and protocol of the European PREFER in VTE Registry 46
Prothrombin complex concentrate such as therapy and prophylaxis in factor X-deficient patient (Friuli Variant) 45
A clinical score to rule out the concomitant presence of deep vein thrombosis in patients presenting with superficial vein thrombosis: The ICARO study 45
Cancers in patients with hemophilia: A retrospective study from the Italian Association of Hemophilia Centers 45
Combined use of antifibrinolytics and activated prothrombin complex concentrate (aPCC) is not related to thromboembolic events in patients with acquired haemophilia A: data from FAIR Registry 42
Regenerative Surgery with Dental Implant Rehabilitation in a Haemophiliac Patient 41
The Italian START-Register on anticoagulation with focus on atrial fibrillation 40
16. The real-life use of rFXIII (catridecacog) in patients with severe Factor XIII deficiency: an Italian survey. 40
Addressing the impact of SARS-CoV-2 infection in persons with congenital bleeding disorders: The Italian MECCOVID-19 study 40
Can the plasmaderived factor VIII still play a role in the treatment of acquired hemophilia A at the time of new drugs? 38
Use of recombinant activated factor VII in severe post-partum haemorrhage: Data from the Italian Registry. A multicentric observational retrospective study 37
Coagulation and oxidative stress plasmatic levels in a type 2 diabetes population 37
Long-term anticoagulant therapy of patients with venous thromboembolism. What are the practices? 37
Efficacy and safety of peripheral blood stem cell mobilization and collection: A single-center experience in 190 allogeneic donors 36
Successful double bypass in a patient with severe hemophilia A: A case report 36
Venous thromboembolism during pregnancy, postpartum or during contraceptive use: Findings from the RIETE Registry 36
Immune tolerance induction with moroctocog-alpha (Refacto/Refacto AF) in a population of Italian haemophilia A patients with high-titre inhibitors: Data from REF.IT Registry 36
Aspirin for preventing the recurrence of venous thromboembolism 35
Demographic and clinical data in acquired hemophilia A: Results from the European Acquired Haemophilia Registry (EACH2) 34
A prognostic score to identify low-risk outpatients with acute deep vein thrombosis in the lower limbs 34
Clinical characteristics and outcome of inpatients versus outpatients with venous thromboembolism: Findings from the RIETE Registry 34
Bleeding complications associated with anticoagulant therapy in patients with cancer 33
Pregnancy-associated acquired haemophilia A: Results from the European Acquired Haemophilia (EACH2) registry 33
The international factor IX treatment network survey 32
Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism 32
Extended Compression Ultrasound Performed by Emergency Physicians: A Modified Compression Ultrasound Examination to Detect Superficial and Deep Lower Limb Thromboses in the Emergency Department 32
Major bleeding as a predictor of mortality in patients with venous thromboembolism: Findings from the RIETE Registry 32
Management of bleeding in acquired hemophilia A: Results from the European Acquired Haemophilia (EACH2) registry 31
Haemophilia A/B carriers: haemorrhagic burden of disease and open issues 31
Retinal vein occlusion: Evaluation of "classic" and "emerging" risk factors and treatment 30
Recurrent venous thromboembolism in anticoagulated patients with cancer: Management and short-term prognosis 30
D-dimer levels and 15-day outcome in acute pulmonary embolism. Findings from the RIETE registry 30
Cancers in Patients with von Willebrand Disease: A Survey from the Italian Association of Haemophilia Centres 29
An Italian Survey on the real-world use of rFXIII (catridecacog) in patients with factor XIII deficiency 29
Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism 28
Clinical course of patients with symptomatic isolated superficial vein thrombosis: the ICARO follow-up study 28
Direct Oral Anticoagulants for Very Elderly People with Atrial Fibrillation: Efficacy and Safe Enough? 28
Treatment With Efmoroctocog Alfa (Elocta®) in Hemophilia: A Case Series 28
Low dose of aPCC after the initial treatment in acquired haemophilia A is useful to reduce bleeding relapses: Data from the FAIR registry 28
Real-Life Population Pharmacokinetics of Recombinant Factor XIII and Dosing Considerations for Preventing the Risk of Bleeding in Patients with FXIII Congenital Deficiency 28
Gender differences in cancer patients with acute venous thromboembolism 27
Immune tolerance induction rescue with turoctocog-alfa in a poor risk haemophilia A inhibitor young child: The history of a success 27
Vanishing bile duct syndrome in non-Hodgkin lymphoma: a case report 27
Thrombophilic mutations as risk factor for retinal vein occlusion: A case-control study 26
Practical use of intermittent pneumatic compression as thromboprophylaxis in neurosurgery 26
Long-term outcomes of patients with cerebral vein thrombosis: A multicenter study 26
PdFVIII/VWF may be an alternative treatment for old medical patient with acquired haemophilia A and systemic vascular disease? 25
Use of Recombinant Activated Factor VII in Severe Post-Partum Haemorrhage: Data from the Italian Registry. A Multicentric Observational Retrospective Study. 25
Savings without changing: How to use the MyPKfit® device to improve treatment strategies in a cohort of patients with haemophilia A 24
Adult patients with mild haemophilia: an under-valued population, but at high risk for intracranial haemorrhage (data from the EMO.REC Registry). 24
An Italian Survey on the real-world use of rFXIII (catridecacog) in patients with Factor XIII deficiency. 24
Safety and efficacy of thromboprophylaxis with fondaparinux in elderly acutely ill medical patients with renal impairment: a retrospective single center study 24
Spontaneous recurrent intracranial haemorrhage in a woman with type 2B von Willebrand disease: A clinical case and a brief literature review 24
Safety of vitamin K antagonist treatment for splanchnic vein thrombosis: A multicenter cohort study 24
Emicizumab in acquired hemophilia A: pros and cons of a new approach to the prevention and treatment of bleeding 23
Home versus in-hospital treatment of outpatients with acute deep venous thrombosis of the lower limbs 23
Identification of low-risk patients with acute symptomatic pulmonary embolism for outpatient therapy 23
Susoctocog-alfa (Obizur®) in the treatment of nine elderly patients with acquired haemophilia A: an Italian multicentre real world experience 23
Infection as cause of immobility and occurrence of venous thromboembolism: analysis of 1635 medical cases from the RIETE registry 23
Intracranial haemorrhage in children and adults with haemophilia A and B: A literature review of the last 20 years 23
A multicenter, real-world experience with recombinant FXIII for the treatment of patients with FXIII deficiency: from pharmacokinetics to clinical practice. The Italian FXIII Study 23
Physical activity improved by adherence to prophylaxis in an Italian population of children, adolescents and adults with severe haemophilia A: The SHAPE Study 22
Two cases of successful Immune Tolerance Induction Rescue (ITI-R) with simoctocog alfa (rhFVIII) in hemophilia A patients and high-titer inhibitors. 22
Venous thromboembolism in patients immobilised at home 22
The successful use of susoctocog-alfa (rpFVIII) in the treatment of nine elderly patients presenting acquired haemophilia A: a multicenter case series 21
Totale 4.471
Categoria #
all - tutte 31.189
article - articoli 30.945
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.134


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020296 0 0 0 24 56 34 45 46 51 19 10 11
2020/2021679 7 18 1 30 6 1 10 27 277 62 21 219
2021/20222.112 65 83 251 123 422 90 134 160 165 33 123 463
2022/2023649 286 12 7 18 70 75 10 37 73 10 32 19
2023/2024691 12 46 39 55 51 59 43 32 31 135 69 119
2024/2025430 16 210 171 33 0 0 0 0 0 0 0 0
Totale 5.508